“…Importantly, the pathways involved in the self-renewal HSCs regulate the levels of ROS, emphasising the importance of redox homeostasis in haematopoiesis. In addition, multiple other proteins and pathways, such as tumour suppressors p53 (TP53) and retinoblastoma protein (RB), glycogen synthase kinase-3 (GSK-3), cyclin dependent kinases (CDK), and BCL2 all play an important role in self-renewal, maintaining quiescence, proliferation, differentiation and survival of HSCs mainly through the modulation of mitochondrial ROS [85]. ROS, therefore, plays an essential role in the quiescence, self-renewal, and long-term survival of HSCs, and hence, elevated, and sustained ROS exposure is likely to contribute to cell cycle progression, DNA damage and the initiation and progression of ALL.…”